Abstract | BACKGROUND: Head circumference (HC) is a simple and practical measure of brain size, development and longitudinal measurements of the HC in childhood are an index of brain growth. OBJECTIVE: To determine the effects of long IGF-I deficiency and treatment on HC in patients with Laron syndrome (LS). PATIENTS: 20 untreated adult LS patients, aged 48.4±11.2 years and 13 LS patients treated between ages of 5.6±4 to 11.3±3 years were studied. 15 patients with congenital IGHD treated between age 6.1±4 and 13±4 by hGH served as controls. METHODS: HC was expressed as standard deviation (SD) and Ht as SDS. HC was measured and plotted on Nellhaus charts. Linear height (Ht) was measured by a Harpenden Stadiometer. CONCLUSIONS: The mean HC deficit of the adult untreated LS males was -2.9±0.6 SD compared to a Ht deficit of -7.0±1.7 SDS. The HC of the LS adult females was -3.6±1 SD compared to a Ht SDS of -6.9±1.5 (p<0.001). IGF-I treatment (150-200 μg/kg once daily) increased the HC from -3.3±0.9 (m±SD) to normal values (0.87±1.8 SD) (p<0.001) in 11/13 children. The Ht SDS deficit decreased only by 1.5 SDS. hGH treatment of cIGHD children increased the HC from -2.0±1.8 to 0.3±1.2 SD and the Ht SDS from -4.8±1.6 to 1.6±1.0.
|
Authors | Zvi Laron, Moshe Iluz, Rivka Kauli |
Journal | Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
(Growth Horm IGF Res)
Vol. 22
Issue 2
Pg. 49-52
(Apr 2012)
ISSN: 1532-2238 [Electronic] Scotland |
PMID | 22414926
(Publication Type: Comparative Study, Journal Article, Review)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Chemical References |
- Human Growth Hormone
- Insulin-Like Growth Factor I
- Growth Hormone
|
Topics |
- Adolescent
- Adult
- Brain
(physiology)
- Case-Control Studies
- Cephalometry
- Child
- Child, Preschool
- Dwarfism, Pituitary
(drug therapy)
- Female
- Growth Hormone
(deficiency)
- Head
(physiology)
- Human Growth Hormone
(metabolism)
- Humans
- Insulin-Like Growth Factor I
(metabolism)
- Laron Syndrome
(drug therapy, physiopathology)
- Male
- Middle Aged
|